A5101740981- Bladder and Urothelial Cancer Treatments
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Renal and related cancers
- Prostate Cancer Treatment and Research
- Urinary and Genital Oncology Studies
- Urologic and reproductive health conditions
- Urological Disorders and Treatments
- Cancer Research and Treatments
- Venous Thromboembolism Diagnosis and Management
- Radiomics and Machine Learning in Medical Imaging
- Renal and Vascular Pathologies
- Cancer Immunotherapy and Biomarkers
- MRI in cancer diagnosis
- Ferroptosis and cancer prognosis
- Cancer Genomics and Diagnostics
- Urinary Bladder and Prostate Research
- Bariatric Surgery and Outcomes
- Gastric Cancer Management and Outcomes
- Nutrition and Health in Aging
- Economic and Financial Impacts of Cancer
- Cardiac, Anesthesia and Surgical Outcomes
- Genetic and Kidney Cyst Diseases
- Pediatric Urology and Nephrology Studies
- Organ Donation and Transplantation
Mayo Clinic
2018-2025
Mayo Clinic in Arizona
2017-2025
WinnMed
2018-2025
Royal Marsden NHS Foundation Trust
2024
Mayo Clinic in Florida
2024
Cleveland Clinic Lerner College of Medicine
2024
American Urological Association
2023
Evidence (Italy)
2023
Michigan Department of Education
2023
Nassau University Medical Center
2022
No AccessJournal of UrologyAdult Urology1 Aug 2016Positive Surgical Margins Increase Risk Recurrence after Partial Nephrectomy for High Renal Tumors Paras H. Shah, Daniel M. Moreira, Zhamshid Okhunov, Vinay R. Patel, Sameer Chopra, Aria A. Razmaria, Manaf Alom, Arvin K. George, Oksana Yaskiv, Michael J. Schwartz, Mihir Desai, Manish Vira, Lee Richstone, Jaime Landman, Arieh L. Shalhav, Inderbir Gill, and Louis Kavoussi ShahParas Shah Department Urology, Smith Institute North Shore LIJ, New...
You have accessJournal of UrologyOriginal Research Articles1 Apr 2024Automated Identification Key Steps in Robotic-Assisted Radical Prostatectomy Using Artificial IntelligenceThis article is commented on by the following:Editorial Comment Abhinav Khanna, Alenka Antolin, Omri Bar, Danielle Ben-Ayoun, Maya Zohar, Stephen A. Boorjian, Igor Frank, Paras Shah, Vidit Sharma, R. Houston Thompson, Tamir Wolf, Dotan Asselmann, and Matthew Tollefson KhannaAbhinav Khanna *Corresponding Author: MD, 200...
We studied recurrence-free survival after partial vs radical nephrectomy for clinical stage T1 renal cell carcinoma in all patients and those up staged to pathological T3a.We retrospectively reviewed the records of 1,250 who underwent or clinically localized between 2006 2014. Recurrence-free was estimated using Kaplan-Meier method evaluated as a function type with log rank test Cox models, adjusting clinical, radiological characteristics.A total 86 recurrences (7%) were observed during...
Data supporting complete metastasectomy of metastatic renal cell carcinoma were derived primarily from the era cytokine therapy. Whether remains beneficial in patients who receive more recently approved systemic therapies has not been well studied. The objective this study was to examine survival outcomes among treated with targeted therapy and checkpoint blockade availability.We queried our institutional nephrectomy registry identified 586 underwent partial or radical unilateral, sporadic a...
To investigate the prognostic significance of various patterns extrarenal extension that comprise pathological stage T3a clear-cell renal cell carcinoma (ccRCC) amongst patients undergoing nephrectomy for non-metastatic disease.A retrospective review 563 who underwent radical pathologically confirmed T3aN0/NxM0 ccRCC between 1970 and 2011 was performed. All slides were re-reviewed by one urological pathologist. Associations (perinephric fat [PF], sinus [SF], vein [RV], in isolation or any...
4597 Background: CG0070, is an Ad5-based oncolytic vaccine engineered to express GM-CSF and replicate selectively in tumor cells with mutated or deficient RB. The CG0070 mechanism of action includes cell lysis immunogenic death which enhanced the presence GM-CSF. In open label ph. 2 study, overall CR rate 62% a at 12 months (m) 29% have been observed patients high risk NMIBC previously treated BCG. IV pembrolizumab, was recently approved by FDA for BCG-unresponsive CIS (with without...
To evaluate whether elective off-clamp laparoscopic partial nephrectomy (LPN) affords long-term renal functional benefit compared with the on-clamp approach.This is a retrospective review of patients who underwent LPN between 2006 and 2011. Patients were followed longitudinally for up to 5 years. In all, 315 radiographic evidence solitary mass normal-appearing contralateral kidney LPN; 209 performed vs 106 off-clamp. One patient required conversion from open PN was excluded study....
Interest has grown in optimizing radical prostatectomy (RP) pathways for prostate cancer, and RP been removed from the Centers Medicare & Medicaid Services inpatient-only list. We aim to determine national trends outpatient RP. The National Inpatient Survey Nationwide Ambulatory Surgery were queried categorize RPs between 2016 2020 as inpatient RPs, comprising same-day discharge (SDD) ambulatory encounters. Trends over time analyzed. Multivariable logistic regression analysis identified...
831 Background: Long non-coding RNA (lncRNA)-based genomic profiling has suggested utility to identify a distinct tumor subgroup corresponding favorable prognosis in patients with bladder cancer. Here, we further evaluate classifier cohort of undergoing radical cystectomy (RC). Methods: Transcriptome-wide expression using Decipher Bladder was performed on TURBT samples from high grade, clinically organ confined (cTa-T2N0M0) UC who subsequently underwent RC without any neoadjuvant therapy...
We evaluated contemporary practice patterns in the management of small renal masses.We identified 52,804 patients NCDB (National Cancer Database) who were diagnosed with a mass (4 cm or less) between 2010 and 2014. Utilization trends active surveillance, ablation robotic, laparoscopic open surgical techniques compared among all comers, elderly 75 years old older individuals competing health risks, defined as Charlson index 2 greater. Multivariable logistic regression models used to assess...
The management of locally recurrent renal-cell carcinoma (RCC) following cryoablation remains a clinical dilemma. There is limited data regarding the disease in setting patients who have failed initial percutaneous (PCA). We evaluate and report our experience with salvage PCA for local recurrence renal failure.We reviewed underwent biopsy proven RCC primary procedures. Complications oncologic outcomes were evaluated. Recurrence-free survival after repeat was plotted using Kaplan-Meier...
Contemporary prostate cancer (PCa) screening modalities such as specific antigen (PSA) and digital rectal examination (DRE) are limited in their ability to predict the detection of clinically significant disease. Multi-parametric magnetic resonance imaging (mpMRI) has been explored a staging modality for PCa. Less is known regarding its utility primary modality. We examined our experience with mpMRI both instrument. studies performed between 2012 2014 patients without PCa were...